Connection

Marcy Bolster to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications Marcy Bolster has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
  1. A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford). 2020 07 01; 59(7):1505-1513.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.